Peanut oral immunotherapy for peanut hypersensitivity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 2 registered trials.

Why this status

  1. 22 Jun 2009: Trial started, NCT00932828
  2. 3 Jul 2009: Trial registered, NCT00932828

The trials

NCT00932828: Determining the Efficacy and Value of Immunotherapy on the Likelihood of Peanut Tolerance: The DEVIL Study

State
Completed
Phase
Phase 2
People
37 taking part
Started
22 Jun 2009
Primary completion
1 Feb 2017
Arms
Peanut oral immunotherapy
Results
Posted on the registry
  1. 22 Jun 2009: Trial started
  2. 3 Jul 2009: Trial registered
  3. 1 Feb 2017: Trial completed
  4. 24 May 2018: Trial results posted

NCT01259804: Study of Tolerance to Oral Peanut

State
Completed
Phase
Phase 1
People
22 taking part
Started
Jan 2008
Primary completion
Jan 2012
Arms
Peanut immunotherapy
Results
None posted
  1. 14 Dec 2010: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.